Side-by-Side Comparison · 2026

Neuropeptide S vs Xenopsin

Neuropeptide S vs Xenopsin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?

Neuropeptide S
Neuropeptide

Neuropeptide S (NPS) is a 20-amino acid peptide discovered in 2004 that acts on the NPS receptor (NPSR1), a Gq/Gs-coupled GPCR with highest expression in amygdala, hypothalamus, and brainstem arousal centers. NPS produces a distinctive combination of simultaneous wakefulness prom...

Calculate Neuropeptide S dose →
Xenopsin
Neuropeptide

Xenopsin is an octapeptide originally isolated from the skin of the South African clawed frog Xenopus laevis. It shares structural similarity with the C-terminal portion of neurotensin and activates neurotensin receptors....

Calculate Xenopsin dose →
Key Parameters
Parameter Neuropeptide S Xenopsin
Category Neuropeptide Neuropeptide
Research Preclinical Preclinical
Half-Life Short (minutes, CNS) Short
Typical Dose 0.1-10 nmol (ICV, animal) N/A (research)
Frequency Variable N/A
Route Intracerebroventricular (animal research) IV / ICV (research)
FDA Status Not approved Not approved

Calculate doses for both

Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.

Frequently Asked Questions
What is the difference between Neuropeptide S and Xenopsin?
Neuropeptide S: Neuropeptide S (NPS) is a 20-amino acid peptide discovered in 2004 that acts on the NPS receptor (NPSR1), a Gq/Gs-coupled GPCR with highest expression in amygdala, hypothalamus, and brainstem arousal ... Xenopsin: Xenopsin is an octapeptide originally isolated from the skin of the South African clawed frog Xenopus laevis. It shares structural similarity with the C-terminal portion of neurotensin and activates n...
Which has a longer half-life, Neuropeptide S or Xenopsin?
Neuropeptide S half-life: Short (minutes, CNS). Xenopsin half-life: Short.
Can you stack Neuropeptide S and Xenopsin?
Neuropeptide S and Xenopsin are in the same category and used together in research protocols. Always consult relevant literature and follow appropriate guidelines.

For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.